Blog
Biopharma leaders and pediatric rare disease experts gathered for the FDA's ADEPT 10 workshop to discuss paths to advance neonatal drug development. This is the definitive recap.
Digital therapeutics (DTx) are becoming a valuable component of pharma’s development and commercialization strategies. When done right, they can help improve drug efficacy and provide valuable support for people with complex, chronic conditions. Biofourmis, a data analytics …
Sign up to receive our monthly newsletter to get exclusive medtech marketing insights and practical writing tips you can use today. You may occasionally get special updates, but very rarely, I promise.
Sign up to receive our monthly newsletter to get exclusive medtech marketing insights and practical writing tips you can use today. You may occasionally get special updates, but very rarely, I promise.